Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Eleonora Petryayeva"'
Autor:
Uvaraj Uddayasankar, Nicole White-Al Habeeb, Eleonora Petryayeva, Saranya Arnoldo, Sukhbir Kaur, Michael J. Knauer, Julie L.V. Shaw, Dana Bailey, Vincent De Guire, Danijela Konforte, Susan M. Poutanen, Edward Randell, Jennifer Taher
Publikováno v:
Clinical Biochemistry
Objectives A consensus guidance is provided for testing, utility and verification of SARS-CoV-2 point-of-care test (POCT) performance and implementation of a quality management program, focusing on nucleic acid and antigen targeted technologies. Desi
Autor:
Eleonora Petryayeva, W. Russ Algar, Eunkeu Oh, Guillermo Lasarte-Aragonés, Kimihiro Susumu, Ajmeeta Sangtani, Igor L. Medintz, James B. Delehanty, Alan L. Huston
Publikováno v:
Bioconjugate Chemistry. 30:525-530
Multidrug resistance (MDR) is a significant challenge in the treatment of many types of cancers as membrane-associated transporters actively pump drugs out of the cell, limiting therapeutic efficacy. While nanoparticle (NP)-based therapeutics have em
Autor:
W. Russ Algar, Michael V. Tran, Igor L. Medintz, Olga Solodova, Kimihiro Susumu, Eleonora Petryayeva, Eunkeu Oh, Hyungki Kim
Publikováno v:
ACS applied materialsinterfaces. 12(47)
Colloidal semiconductor quantum dots (QDs), metal nanoparticles, and cellulose paper are materials with numerous applications in bioanalysis and beyond. The functional properties of QDs and metal NPs are substantially different than those of cellulos
Publikováno v:
The Canadian journal of cardiology. 35(11)
Publikováno v:
Clinica chimica acta; international journal of clinical chemistry. 498
Publikováno v:
The Journal of Physical Chemistry C. 119:26183-26195
The unique optical properties of semiconductor quantum dots (QDs) are highly advantageous for biological imaging and analysis, particularly when combined with Forster resonance energy transfer (FRET). A recent innovation in this area has been concent
Autor:
Miao Wu, Kimihiro Susumu, Ajmeeta Sangtani, Alan L. Huston, Eunkeu Oh, James B. Delehanty, Igor L. Medintz, Guillermo Lasarte-Aragonés, Eleonora Petryayeva, W. Russ Algar
Publikováno v:
Colloidal Nanoparticles for Biomedical Applications XIII.
Nanoparticle (NP)-mediated drug delivery offers the potential to overcome limitations of systemic delivery, including the ability to specifically target cargo and control release of NP-associated drug cargo. Doxorubicin (DOX) is a widely used FDA-app
Autor:
James B. Delehanty, Miao Wu, Alan L. Huston, Eleonora Petryayeva, Ajmeeta Sangtani, Eunkeu Oh, Guillermo Lasarte-Aragonés, Kimihiro Susumu, Igor L. Medintz, W. Russ Algar
Publikováno v:
Bioconjugate chemistry. 29(1)
Nanoparticle (NP)-mediated drug delivery (NMDD) has emerged as a novel method to overcome the limitations of traditional systemic delivery of therapeutics, including the controlled release of the NP-associated drug cargo. Currently, our most advanced
Autor:
Eleonora Petryayeva, W. Russ Algar
Publikováno v:
The Analyst. 140:4037-4045
The development of nanoparticle-based bioassays is an active and promising area of research, where point-of-care (POC) diagnostics are one of many prospective applications. Unfortunately, the majority of nanoparticle-based assays that have been devel
Autor:
Eleonora Petryayeva, W. Russ Algar
Publikováno v:
RSC Advances. 5:22256-22282
There is a critical need for point-of-care (POC) diagnostics in health care and a parallel need for similar point-of-need (PON) diagnostics in other sectors. Such technology could have a profoundly positive impact on health, wellness and quality-of-l